The transcription factor CREM drives an inflammatory phenotype of T cells in oligoarticular juvenile idiopathic arthritis

Abstract

BackgroundInflammatory effector T cells trigger inflammation despite increased numbers of Treg cells in the synovial joint of patients suffering from juvenile idiopathic arthritis (JIA). The cAMP response element (CREM)α is known to play a major role in regulation of T cells in SLE, colitis, and EAE. However, its role in regulation of effector T cells within the inflammatory joint is unknown.MethodsCREM expression was analyzed in synovial fluid cells from oligoarticular JIA patients by flow cytometry. Peripheral blood mononuclear cells were incubated with synovial fluid and analyzed in the presence and absence of CREM using siRNA experiments for T cell phenotypes. To validate the role of CREM in vivo, ovalbumin-induced T cell dependent arthritis experiments were performed.ResultsCREM is highly expressed in synovial fluid T cells and its expression can be induced by treating healthy control PBMCs with synovial fluid. Specifically, CREM is more abundant in CD161+ subsets, than CD161− subsets, of T cells and contributes to cytokine expression by these cells. Finally, development of ovalbumin-induced experimental arthritis is ameliorated in mice with adoptively transferred CREM−/− T cells.ConclusionIn conclusion, our study reveals that beyond its role in SLE T cells CREM also drives an inflammatory phenotype of T cells in JIA.

Therapeutic strategies for targeting telomerase in cancer

“…This indicates that the death of tumor cells is caused by the activation of DDR inside cells . In addition, T‐oligo has been shown to activate the ATM pathway in melanoma and human breast cancer cell lines, inducing upregulation and phosphorylation of ATM and its downstream effectors p53, p73, p95/Nbs1, E2F1, p21, and BAX . Previous studies have suggested that the mechanisms of T‐oligo are independent of telomerase and telomerase subunits.…”

CD101 genetic variants modify regulatory and conventional T cell phenotypes and functions

“…Many genes were also increased in expression in CD4 + T cells with CD101 rs12093834 or rs34248572 compared with no variants. Notably, expression of CREM, which encodes a transcriptional activator of T cells that has been shown to contribute to T cell dysregulation in autoimmune conditions, [17][18][19][20] was increased in CD4 + T cells from individuals with an Ig-like variant or a cytoplasmic variant (Figures 5B and 5C). Thus, increased expression of CREM could lead to a dysregulated and inflammatory T cell profile, but additional experiments to investigate the effects of ectopic expression of this gene are required to validate this possibility.…”

T-Cell Compartmentalization and Functional Adaptation in Autoimmune Inflammation: Lessons From Pediatric Rheumatic Diseases

“…One mechanism that explains the elevated production of IL-17 in JIA and SLE is the increased expression of the transcription factor cAMP-responsive element modulator (CREM)α. This induces repression of IL-2 transcription but also epigenetic changes of the IL-17A locus, resulting in enhanced IL-17A promoter activity (24, 25). Although evidence for involvement of the IL-17 signaling pathway in SLE pathogenesis is expanding, direct interference with IL-17 or it's receptor does not seem to be effective, at least in mouse models (26, 27).…”